Through a new partnership, Zocdoc’s technology has been embedded within Blue Shield of California’s “Find a Doctor” feature. Members can now log in and find real-time availability of providers in their network and book appointments within a 90-day window directly through the insurer’s website. The post Blue Shield of California, Zocdoc Partner To Help Members…
AstraZeneca’s R&D collaboration with CSPC Pharmaceutical Group includes an oral small molecule for immunological diseases, which would offer a dosing edge over currently available injectable medications. The agreement follows a 2024 licensing agreement that granted AstraZeneca rights to an oral CSPC drug candidate in development for a metabolic disorder. The post AstraZeneca Turns to CSPC…
In the past, arbitrary maintenance schedules and planned downtime were necessary expenses. Now we have the tools to think and work differently The post Maximizing Equipment Uptime with Predictive Maintenance Technologies appeared first on MedCity News.
Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression. The post How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions appeared first on MedCity News.
[Sponsored] Therapists rely on practice management software to maintain seamless and compliant integration between their administrative and clinical departments. The post The Essential Guide to Practice Management Software for Therapists appeared first on MedCity News.
Many healthcare experts are calling Omada Health and Hinge Health’s IPO debuts a success, though it’s still early days. The post Omada & Hinge’s IPO Debuts Signal Success for Digital Health Market, Experts Say appeared first on MedCity News.
Through a new acquisition, Amino Health will become Capital Rx’s patient-facing care navigation solution called Judi Care. The post Capital Rx Expands Into Care Navigation with Acquisition of Amino Health appeared first on MedCity News.
Bristol Myers Squibb is licensing global rights to a Philochem program in development for both diagnostic imaging and targeted treatment of prostate cancer. It follows the pharma giant’s entry into radiopharmaceuticals via the $4.1 billion acquisition of RayzeBio last year. The post Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to…
The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than 1,000 employees this year; and moving to end billions in funds to partner institutions overseas. The post ‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the…
Managing routine radiology does not require the administrative burden of prior authorization. Instead, health plans can implement post-service, pre-payment automated management based on clinical guidelines. The post Managing Routine Radiology: An Opportunity to Control Costs and Improve Care appeared first on MedCity News.